相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
Leslie M. Shaw et al.
ACTA NEUROPATHOLOGICA (2011)
Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid
Stephen D. Weigand et al.
ALZHEIMERS & DEMENTIA (2011)
Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline
Kristine Yaffe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
Leonardo Cruz de Souza et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment
Ma Fei et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Association of Plasma Aβ Peptides with Blood Pressure in the Elderly
Jean-Charles Lambert et al.
PLOS ONE (2011)
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
William J. Jagust et al.
ALZHEIMERS & DEMENTIA (2010)
Malignant Astrocytomas A System Disease
Hassan M. Fathallah-Shaykh
ARCHIVES OF NEUROLOGY (2010)
Longitudinal Changes in White Matter Disease and Cognition in the First Year of the Alzheimer Disease Neuroimaging Initiative
Owen Carmichael et al.
ARCHIVES OF NEUROLOGY (2010)
Plasma β-Amyloid and Cognitive Decline
Stephanie A. Cosentino et al.
ARCHIVES OF NEUROLOGY (2010)
Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
P. Lewczuk et al.
EXPERIMENTAL NEUROLOGY (2010)
Plasma Aβ42 and Aβ40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study
T. T. Seppala et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical characterization
R. C. Petersen et al.
NEUROLOGY (2010)
Change in plasma Aβ peptides and onset of dementia in adults with Down syndrome
N. Schupf et al.
NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
Anne M. Fagan et al.
EMBO MOLECULAR MEDICINE (2009)
THE INFLUENCE OF MATRIX TYPE, DIURNAL RHYTHM AND SAMPLE COLLECTION AND PROCESSING ON THE MEASUREMENT OF PLASMA β-AMYLOID ISOFORMS USING THE INNO-BIA PLASMA Aβ FORMS MULTIPLEX ASSAY
D. R. Lachno et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
EVOLUTION OF Aβ42 AND Aβ40 LEVELS AND Aβ42/Aβ40 RATIO IN PLASMA DURING PROGRESSION OF ALZHEIMER'S DISEASE: A MULTICENTER ASSESSMENT
K. Blennow et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Association of plasma amyloid β with risk of dementia The prospective Three-City Study
J. -C. Lambert et al.
NEUROLOGY (2009)
Plasma amyloid β-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease
Joseph J. Locascio et al.
ARCHIVES OF NEUROLOGY (2008)
Plasma β amyloid and the risk of Alzheimer disease and dementia in elderly men
Johan Sundelof et al.
ARCHIVES OF NEUROLOGY (2008)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods
Clifford R. Jack et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
O. L. Lopez et al.
NEUROLOGY (2008)
Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease
Nicole Schupf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Association of low plasma Aβ42/Aβ40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease
Neill R. Graff-Radford et al.
ARCHIVES OF NEUROLOGY (2007)
Plasma Aβ1-40 and Aβ1-42 and the risk of dementia:: a prospective case-cohort study
Marieke van Oijen et al.
LANCET NEUROLOGY (2006)
Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
ME Gurol et al.
NEUROLOGY (2006)
Plasma amyloid β protein 42 in non-demented persons aged 75 years:: Effects of concomitant medication and medial temporal lobe atrophy
I Blasko et al.
NEUROBIOLOGY OF AGING (2005)
Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions
EJ van Dijk et al.
ANNALS OF NEUROLOGY (2004)
Plasma Aβ40 and Aβ42 and Alzheimer's disease -: Relation to age, mortality, and risk
R Mayeux et al.
NEUROLOGY (2003)
Age but not diagnosis is the main predictor of plasma amyloid β-protein levels
H Fukumoto et al.
ARCHIVES OF NEUROLOGY (2003)
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents
CA Mathis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Serum creatinine levels correlate with plasma amyloid β protein
Z Arvanitakis et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2002)
Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
PD Mehta et al.
NEUROSCIENCE LETTERS (2001)
分享论文
